All times are approximate and subject to change without notice
(Four Parallel Conferences - click to view detailed agenda)
 
Day 1 - Monday, November 7, 2016
 
7:00
Registration & Continental Breakfast
 
8:00
I. Tumor Microenvironment
II. New Targets for Cancer Drug Development
 
 
10:00
Morning Networking Break
 
10:30
II. Immunomodulatory Antibodies
III. Emerging Technologies and Next Generation Sequencing in Cancer Diagnostics
 
 
12:10
Lunch Provided by GTCbio
 
1:40
III. T-Cell Based Therapies
IV. Cell-Free DNA and RNA
as Non-Invasive Cancer Biomarkers
 
 
3:20
Afternoon Networking Break
 
3:50
IV. The Future of Combination Immunotherapy
V. Clinical Applications of Exosomes and CTCs
as Liquid Biopsy
 
 
5:35
Networking Reception & Poster Session
 
 
 
Day 2 - Tuesday, November 8, 2016
 
7:00
Continental Breakfast
 
8:00
VI. Immunogenic Cell Death & Novel Ways
to Increase Tumor Immunogenicity
I. Nanotechnology and Tissue/Cell Engineering
for Cancer Diagnostics.
 
 
9:20
VII. Immunity and Immunosuppression
Meet Targeted Therapies
 
 
 
9:45
Morning Networking Break
 
10:40
V. Precision Medicine and Biomarkers for Immuno-Oncology
VI. Predictive Markers for Immunotherapy and
Immune-Oncology
 
 
11:55
Conference Concludes & Lunch by GTCbio
 
12:00
Registration
 
1:25
Opening Remarks
 
1:30
Keynote Presentation :
I. Novel Epigenetic Targets in Cancer
Keynote Presentation :
I. Advances & Technologies in Oncology
 
 
3:30
Afternoon Networking Break
 
4:25
 
II. Investments, Partnerships & Acquisitions:
Trends & Recent Deals
 
 
4:50
II. Histone Variants and Histone Modifications
 
 
 
4:45
Networking Reception & Poster Session
 
 
 
Day 3 - Wednesday, November 9, 2016
 
7:30
Continental Breakfast
 
8:00
III. Non-Coding RNA
III. Innovative Partnering & Deal-Making for Value Creation
 
 
10:10
Morning Networking Break
 
10:40
IV. Genetic & Epigenetic Changes: Cancer Stem Cells
VI. The World of PD1 Inhibitors – First and Second Generation
and Future Disrupters
 
 
11:30
 
V. Creating Licensing Value
 
 
12:20
Lunch Provided by GTCbio
 
1:30
V. Epigenetic Tools and Technologies
 
 
 
2:20
 
IV. Biotech Strategies for Self Commercialization
 
 
3:10
Afternoon Networking Break
 
3:35
VI. Epigenetic Mechanism of Drug Resistance
 
 
 
4:50
Conference Concludes
 


Please come back and visit this page for updates!

cancer-therapeutics-summit Agenda